At Guard-Ex, we are developing a non-invasive universal impairment detection device. With the use of machine learning, The Guard will use biological vital signs to accurately measure and detect impairment in the given moment. Along with Alcohol, The Guard will be able to detect impairment derived from mono and polydrug use, quite importantly; Cannabis, Cocaine & Opiates.
The GX-420 is a portable device that uses artificial intelligence & one's physiological indicators to detect real-time impairment. At Guard-Ex, we are developing a non-invasive universal impairment detection device. With the use of machine learning. The Guard will use biological vital signs to accurately measure and detect impairment in the given moment. Along with Alcohol.
Total Funding: $1M
Funding Stage: Seed
Business Stage: Scaling Up
Market: B2G, B2C, B2B
Company Size: 1 to 25
Founded: 2017
